Literature DB >> 16076369

Treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis.

Takuro Kanekura1, Koichi Kawahara, Ikuro Maruyama, Tamotsu Kanzaki.   

Abstract

Pyoderma gangrenosum is an intractable skin disorder characterized by the development of erythematous pustules or nodules that rapidly progress to destructive, necrotizing, non-infective ulcers. We assessed the efficacy of granulocyte and monocyte adsorption apheresis (GCAP) therapy in two new patients, a 67-year-old man with ulcerations on his lower leg, and a 44-year-old man with turgid erythematous lesions with burrowing abscesses and sinus formation on his hip, groin, and thighs. Both patients received 10 GCAP treatments at 5-day intervals. Their skin lesions responded well. The 9 cmx6 cm ulcer on the lower right leg of the 67-year-old patient was completely covered by regenerated skin at the completion of therapy. The turgid skin lesions containing pustules and ulcers of the other patient showed amelioration and a marked decrease in the volume of exudate. Our results suggest that GCAP is a useful treatment modality for pyoderma gangrenosum.

Entities:  

Mesh:

Year:  2005        PMID: 16076369     DOI: 10.1111/j.1744-9987.2005.00284.x

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  7 in total

1.  Successful treatment of pyoderma gangrenosum with granulocyte and monocyte adsorption apheresis.

Authors:  Irene Russo; Serena Miotto; Anna Colpo; Piero Marson; Tiziana Tison; Anna Ferrazzi; Mauro Alaibac
Journal:  Int Wound J       Date:  2016-10-28       Impact factor: 3.315

2.  Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6/SHP1) may contribute to neutrophilic dermatoses.

Authors:  Andrew B Nesterovitch; Zsuzsa Gyorfy; Mark D Hoffman; Ellen C Moore; Nada Elbuluk; Beata Tryniszewska; Tibor A Rauch; Melinda Simon; Sewon Kang; Gary J Fisher; Katalin Mikecz; Michael D Tharp; Tibor T Glant
Journal:  Am J Pathol       Date:  2011-03-04       Impact factor: 4.307

Review 3.  Use of granulocyte and monocyte adsorption apheresis in dermatology (Review).

Authors:  Laura Gnesotto; Guido Mioso; Mauro Alaibac
Journal:  Exp Ther Med       Date:  2022-06-24       Impact factor: 2.751

Review 4.  Cytapheresis for pyoderma gangrenosum associated with inflammatory bowel disease: A review of current status.

Authors:  Kentaro Tominaga; Kenya Kamimura; Hiroki Sato; Masayoshi Ko; Yuzo Kawata; Takeshi Mizusawa; Junji Yokoyama; Shuji Terai
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

5.  Infliximab- and immunosuppressant-resistant Crohn's disease successfully treated with adsorptive granulocyte apheresis combined with prednisolone.

Authors:  Munenori Itagaki; Masayuki Saruta; Toshio Iinuma; Seiji Arihiro; Tomohiro Kato; Hisao Tajiri
Journal:  Case Rep Gastroenterol       Date:  2012-02-22

Review 6.  Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

Authors:  Carlo Alberto Maronese; Matthew A Pimentel; May M Li; Alex G Ortega-Loayza; Angelo Valerio Marzano; Giovanni Genovese
Journal:  Am J Clin Dermatol       Date:  2022-05-24       Impact factor: 6.233

Review 7.  Leukocytapheresis in patients with inflammatory bowel diseases.

Authors:  Małgorzata Woźniak; Ilona Kurnatowska; Ewa Małecka-Panas; Renata Talar-Wojnarowska
Journal:  Prz Gastroenterol       Date:  2021-06-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.